Enis Tinjak*, Velda Smajlbegović, Nusret Salkica and Teufik Orahovac

Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina

*Corresponding Author: Enis Tinjak, Medical Radiology Technologist, RTT, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.

Received: June 28, 2021; Published: August 07, 2021

Abstract

Stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) have become important treatment modalities for brain tumors. A technique that delivers a high dose of radiation, with effective use in patients with life-limiting diseases. Due to its specificity, the precision and direct visualization of the target during the delivery of the treatment is very important. The aim of this research article is to provide the safety and long-term efficacy of SRS and SRT. This research article, also, provides accuracy of the SRS treatment performed on linear accelerator and use of the trUpoint ARCH SRS system for patient imobilization.

Keywords: Stereotactic Radiosurgery; Radiotherapy; Brain Metastases and Tumors; Linear Accelerator

References

1. Kim Y-J., et al. “Single-Dose Versus Fractionated Stereotactic Radiotherapy for Brain Metastases”. International Journal of Radiation Oncology*Biology*Physics2 (2011): 483-489.
2. Dumont Lecomte D., et al. “Hypofractionated stereotactic radiotherapy for challenging brain metastases using 36 Gy in six fractions”. Cancer/Radiothérapie8 (2019): 860-866.
3. https://www.mayoclinic.org/tests-procedures/stereotactic-radiosurgery/about/pac-20384526
4. Halasz LM and Rockhill JK. “Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases”. Surgical Neurology International 4 (2013):
5. Sanad MH., et al. “Radiocomplexation and bioevaluation of 99mTc nitrido-piracetam as a model for brain imaging”. Radiochimica Acta 105 (2017): 729.
6. Sanad MH and Alhussein AI. “Preparation and biological evaluation of 99mTc N histamine as a model for brain imaging: in silico study and preclinical evaluation”. Radiochimica Acta 106 (2018): 229.
7. Amin AM., et al. “Radiochemical and biological characterization of 99mTc-piracetam for brain imaging”. Radiochemistry 55 (2013): 624.
8. Sanad MH., et al. “99mTc-Oxiracetam as a potential agent for diagnostic imaging of brain: labeling, characterization, and biological evaluation”. Radiochemistry 60 (2018): 58.
9. Sanad MH., et al. “Radioiodination and bioevaluation of rolipram as a tracer for brain imaging: in silico study, molecular modeling and gamma scintigraphy”. Journal of Labelled Compounds and Radiopharmaceuticals 61 (2018): 501.
10. Zhang J., et al. “Synthesis and biodistribution of the 99mTc (CO)3-DEDT complex as a potential new radiopharmaceutical for brain imaging”. Journal of Radioanalytical and Nuclear Chemistry 272 (2007): 91.
11. Satpati D., et al. “Preparation and bioevaluation of 99mTc-carbonyl complex of 5-hydroxy tryptamine derivative”. Applied Radiation and Isotopes 64 (2006): 888.
12. Erfani M., et al. “Synthesis and biological evaluation of 99mTc (CO)3-OH-PP-CS2 for brain receptor imaging”. Iranian Journal of Nuclear Medicine 20 (2012): 25.

Citation

Citation: Enis Tinjak., et al. “Stereotactic Radiosurgery and Stereotactic Radiotherapy for Brain Tumors”.Acta Scientific Medical Sciences 5.9 (2021): 12-17.

Copyright

Copyright: © 2021 Enis Tinjak., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.